Insights that make
benefits measurable.

PBM economics, GLP-1 control architecture, stop-loss strategy, and governance—written for CFOs and CHROs who want evidence, not noise.

Featured Insight

CFO

Benefits Isn't "HR Spend." It's a Financial System.

Most organizations treat benefits like weather: it happens, it's expensive, and everyone shrugs. That mindset is how you end up with 'trend' as an explanation instead of an actual model.

4 min read

Pharmacy

"Pass-Through" Isn't a Strategy (And Sometimes Isn't Real)

"Pass-through" sounds like transparency. In practice, it's often a label that hides where margin is still retained: specialty classification, network differentials, MAC list games, admin fees.

3 min read

Read

GLP-1

GLP-1: The First Drug Category That Acts Like a Budget Line

GLP-1 doesn't behave like "normal Rx." It behaves like a budget line with a growth curve. If you don't manage it, it will manage you.